KBLB Kraig Biocraft Laboratories, Inc.
Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) · OTC · SEC CIK 1413119 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-5.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-127.4%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets300.7%
Debt / equity—
Current ratio0.27x
Interest coverage-5.67x
Cash quality & payout
Operating cash flow / net income0.56x
Accruals ratio-56.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $165,758 | $164,374 |
| SG&A expense | $1.96M | $1.75M |
| Operating income | -$3.37M | -$3.07M |
| Interest expense | $570,709 | $529,603 |
| Pretax income | -$3.62M | -$3.40M |
| Net income | -$3.62M | -$3.40M |
| EBITDA | -$3.35M | -$3.05M |
| EPS (basic) | 0.00 | 0.00 |
| EPS (diluted) | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 1.06B | 1.04B |
| Balance sheet | ||
| Cash & equivalents | $1.79M | $673,264 |
| Short-term investments | $0 | $0 |
| Inventory | $29,067 | $6,884 |
| Current assets | $1.87M | $740,285 |
| PP&E, net | $25,003 | $44,721 |
| Total assets | $2.57M | $1.51M |
| Current liabilities | $10.45M | $9.61M |
| Total liabilities | $10.56M | $9.65M |
| Shareholders' equity | -$8.00M | -$8.15M |
| Cash flow statement | ||
| Operating cash flow | -$1.79M | -$1.84M |
| Capital expenditure | $5,395 | $4,240 |
| Free cash flow | -$1.79M | -$1.84M |
| Investing cash flow | $438,042 | -$4,240 |
| Financing cash flow | $2.47M | -$35,244 |
| Depreciation & amortization | $25,113 | $26,159 |
| Stock-based compensation | $87,285 | — |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.